Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | KeraHeal? | Company | Biosolution Co., Ltd. |
|---|---|---|---|
| Classification | Cell Therapy product | Active Ingredient | Autologous skin-derived keratinocytes |
| Reference Product | Approval Date | 2006 | |
| Indication | 1. Deep 2nd degree burns that cover more than 30% of TBSA 2. 3rd degree burns that cover more than 10% of TBSA |
||
| Description |
KeraHeal? is a spray-type autologous keratinocyte therapy product that has received product approval in 2006 by the MFDS. Keratinocytes are separated and cultured from the patient’s normal skin, which then form a new epidermal layer on the wound through engraftment and duplication. KeraHeal? is composed of keratinocytes that cultivate, but do not differentiate which in turn shows a high take rate. |
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.